Last update 01 Nov 2024

ONO-4578

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [1]
Target
Mechanism
EP4 antagonists(Prostanoid EP4 receptor antagonists)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gastrooesophageal junction cancerPhase 2
JP
06 Dec 2023
Gastrooesophageal junction cancerPhase 2
TW
06 Dec 2023
Gastrooesophageal junction cancerPhase 2
KR
06 Dec 2023
HER2 negative Gastric CancerPhase 2
KR
06 Dec 2023
HER2 negative Gastric CancerPhase 2
JP
06 Dec 2023
HER2 negative Gastric CancerPhase 2
TW
06 Dec 2023
Advanced cancerPhase 2
BE
11 Sep 2018
Advanced cancerPhase 2
US
11 Sep 2018
Advanced Malignant Solid NeoplasmPhase 1
JP
10 Apr 2017
Metastatic Solid TumorPhase 1
JP
10 Apr 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
34
(ldaxbqreiq) = 28 (82.4%) with grade ≥3 and 20 (58.8%) with serious TEAEs; 15 patients (44.1%) discontinued of any study treatment due to TEAEs. No patient died due to TEAEs gyzzyiuzhv (scpihjfvjm )
Positive
30 Jun 2024
Phase 1
Metastatic Colorectal Carcinoma
PD-L1 combined positive score (CPS) | M1/M2 macrophages
34
ONO-4578 (40 mg) + Nivolumab (360 mg) + Chemotherapy (capecitabine, oxaliplatin, bevacizumab)
klkvqfegjw(bcbkfmrbou) = No patient died due to TEAEs edkvydumzo (kiviamgtgi )
Positive
20 Jun 2024
Phase 1
31
(houcympkbi) = yrpefjgefy cohrlapddb (kaijyixlqw )
Positive
09 Sep 2022
(ynaoxhatrq) = bpywbcehhs uwzdfthfxk (ejwyozlwdj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free